Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px
Organisation › Details

Biocartis (Group)

Biocartis aims to improve healthcare outcomes by enabling the practice of personalized medicine anywhere, anytime. Biocartis' ambition is to establish a new gold standard in diagnostic testing. Biocartis provides innovative research and diagnostic systems with multiplex detection and simplified workflows which require less hands-on time and minimize sample requirements (especially for tumor biopsies). Additionally, Biocartis develops assays which have high clinical utility and compelling health economic value. Oncology is the primary focus of Biocartis as this is one of the greatest unmet needs for personalized medicine. Biocartis is well suited to address the growing need for individualized diagnosis and treatment of cancer patients. Biocartis is a rapidly growing company; to date Biocartis staff includes over 140 people. The company has raised in total EUR 125 million in equity. *

 

Period Start 2007-01-01 established
Products Industry molecular diagnostics
  Industry 2 cancer test
Persons Person Pauwels, Rudi (Biocartis 201111 Executive Chairman before 201002–201111 CEO)
  Person 2 Welten, Ewoud (Biocartis 201607 CFO)
     
Region Region Mechelen
  Country Belgium
  Street 11 B3 Gen. De Wittelaan
  City 2800 Mechelen
  Tel +32-15-632-600
    Address record changed: 2016-11-22
     
Basic data Employees D: 101 to 500 (2018-12-31)
  Currency EUR
  Annual sales 28,651,000 (operating income, consolidated (2018) 2018-12-31)
  Profit -48,153,000 (2018-12-31)
  Cash 63,539,000 (2018-03-31)
     
    * Document for �About Section�: Biocartis S.A.. (12/5/12). "Press Release: Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform". Lausanne.
     
   
Record changed: 2019-04-23

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Biocartis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top